Hayward, CA, United States of America

Dianne M Fishwild

This inventor holds 1 USPTO granted patent. Top assignee: Xoma Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dianne M Fishwild. Retrieved from https://idiyas.com/inventor/dianne-m-fishwild-nbld47s4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 430(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dianne M Fishwild: Innovator in Antibody Technology

Introduction

Dianne M Fishwild is a prominent inventor based in Hayward, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of modified antibody variable domains. Her innovative work has led to advancements in therapeutic applications.

Latest Patents

Dianne holds 1 patent for her invention related to modified antibody variable domains. This patent showcases her expertise and commitment to enhancing antibody technology, which is crucial for various medical treatments.

Career Highlights

Dianne is currently employed at Xoma Corporation, a company known for its focus on developing innovative antibody-based therapeutics. Her role at Xoma Corporation allows her to apply her knowledge and skills in a collaborative environment, driving forward the company's mission to improve patient outcomes.

Collaborations

Throughout her career, Dianne has worked alongside notable colleagues such as Gary M Studnicka and Roger G Little, II. These collaborations have fostered a dynamic exchange of ideas and expertise, contributing to the success of their projects.

Conclusion

Dianne M Fishwild is a dedicated inventor whose work in modified antibody technology has the potential to impact the medical field significantly. Her contributions at Xoma Corporation and her collaborations with esteemed colleagues highlight her importance in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…